Last reviewed · How we verify

NCT04554212: BRAINS

Blood Flow Restriction Training After Patellar INStability

Recruiting now NA Last updated 3 July 2025
What this trial tests

NA trial testing Blood Flow Restriction Training in Patellar Dislocation in 78 participants. Currently enrolling.

Timeline
9 September 2020
Primary endpoint
30 June 2026
30 June 2026

Quick facts

Lead sponsorCaitlin Conley
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment78
Start date9 September 2020
Primary completion30 June 2026
Estimated completion30 June 2026
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Caitlin Conley

Who can join

Adults 14 to 40, any sex, with Patellar Dislocation or Knee Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research study is designed to allow health care professionals and researchers to answer many questions about whether a new type of physical therapy called blood flow restriction training (called BFRT) will improve recovery for those with patellar instability.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Blood flow Restriction training After patellar INStability (BRAINS Trial).
    Brightwell BD, Stone A, Li X, Hardy P, et al · · 2022 · cited 5× · PMID 35090543 · DOI 10.1186/s13063-022-06017-1

Verify or expand the search:

Other trials of Blood Flow Restriction Training

Trials testing the same drug.

Other recruiting trials for Patellar Dislocation

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04554212.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing